UFP TECHNOLOGIES INC (UFPT) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$291.32

From 52W high−12.42%

Volume98100.00

Market cap$2.27B

P/E (TTM)31.3x

P/S (TTM)3.6x

Div yield—

Key dataOct 19, 2026

Open

$291.32

From 52W high

−12.42%

Volume

98100.00

Market cap

$2.27B

ValuationView details →

P/E (Fwd)

28.1x

EV/EBITDA

20.7x

P/E (TTM)

31.3x

RSI (14)

50.9

MomentumView details →

1D Return

+0.54%

YTD Return

+32.27%

SummaryUpdated Jun 1, 2026

UFP Technologies, Inc. (NASDAQ:UFPT) is a specialized manufacturing company founded in 1963 and headquartered in Newburyport, Massachusetts. The company went public in 1993 and has evolved from a general foam and plastics manufacturer into a focused provider of engineered components and packaging solutions, with particular strength in the medical device industry. UFP Technologies designs and custom manufactures components, subassemblies, products, and packaging using specialized foams, films, and plastics, serving customers across medical, automotive, aerospace, consumer, and industrial markets.

Ask drillr about UFP TECHNOLOGIES INC →

ValuationView details →

P/E (Fwd)

28.1x

P/E (TTM)

31.3x

EV/EBITDA

20.7x

EV/Sales

3.8x

P/S (TTM)

3.6x

P/B (TTM)

4.9x

ProfitabilityView details →

Gross Margin

28.50%

Net Margin

11.45%

EBITDA Margin

18.38%

ROE (TTM)

15.63%

ROA (TTM)

10.60%

Asset Turnover

0.93x

GrowthView details →

Revenue YoY

+7.32%

EPS YoY

+7.22%

FCF YoY

−15.33%

Revenue CAGR 3Y

+19.44%

EPS CAGR 3Y

+17.13%

EBITDA YoY

+3.09%

MomentumView details →

1D Return

+0.54%

YTD Return

+32.27%

1Y Return

+48.88%

RSI (14)

50.9

vs 50D SMA

−0.96%

vs 200D SMA

+18.74%

Capital & dividendView details →

Debt/Equity

0.29x

Current Ratio

3.00x

Quick Ratio

1.72x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$2.69

EPS Surprise

16.45%

Beats (12Q)

10/12

Next Q EPS Est

$2.34

Avg Surprise (4Q)

13.20%

Rev Surprise

9.15%

Financials snapshotView financials →

Revenue (TTM)

631.64M

Net Income (TTM)

72.30M

Op. CF (TTM)

71.58M

Next earningsNov 2, 2026 →

Latest newsMore news →

R. Jeffrey Bailly was elected as a Class I director of H.B. Fuller Company effective September 23, 2026, receiving an initial grant of 1,300 restricted stock units.21d ago

De Lisle Partners LLP acquired a new stake of 74,302 shares in UFP Technologies, Inc. during the second quarter, as disclosed in its Form 13F filing.58d ago

Similar companies

Guangdong True Health Medical Technology Development Co., Ltd.02697.HK TransMedics Group, Inc.TMDX AxoGen, Inc.AXGN 奥精医疗688613.SH 康拓医疗688314.SH Inspire Medical Systems, Inc.INSP Find similar companies →

Latest newsMore news →

R. Jeffrey Bailly was elected as a Class I director of H.B. Fuller Company effective September 23, 2026, receiving an initial grant of 1,300 restricted stock units.21d ago De Lisle Partners LLP acquired a new stake of 74,302 shares in UFP Technologies, Inc. during the second quarter, as disclosed in its Form 13F filing.58d ago